Table 2.
Patient no. | Tpl2-Norma | Fold increase (R)b | CV(%)-Rc |
Ctr (n = 3) | 0.04 ± 0.019 | 1.00 ± 0.119 | 45.3 |
1 | 0.02 ± 0.000 | 0.59 ± 0.009 | 1.6 |
2 | 0.13 ± 0.005 | 3.88 ± 0.149 | 3.8 |
3 | 0.13 ± 0.005 | 4.04 ± 0.143 | 3.5 |
4 | 0.02 ± 0.003 | 0.66 ± 0.092 | 13.9 |
5 | 0.04 ± 0.005 | 1.22 ± 0.092 | 11.8 |
6 | 0.06 ± 0.003 | 1.70 ± 0.085 | 5.0 |
7 | 0.06 ± 0.002 | 1.81 ± 0.076 | 4.2 |
8 | 0.17 ± 0.008 | 5.21 ± 0.251 | 4.8 |
9 | 0.01 ± 0.000 | 0.32 ± 0.007 | 2.2 |
10 | 0.16 ± 0.006 | 5.04 ± 0.194 | 3.8 |
11 | 0.04 ± 0.001 | 1.09 ± 0.037 | 3.4 |
12 | 0.04 ± 0.004 | 1.22 ± 0.108 | 8.9 |
a. Tpl2/Cot normalized to GAPDH by equation (3) in the text ± SD.
b. Tpl2/Cot-Norm (sample) ratio to Tpl2/Cot-Norm (control) by equation (2) in the text ± SD. Samples in which Tpl2/Cot is overexpressed are shown in bold.
c. % Coefficient variance of (R).